Stryker Stock Quote Today

<div class='circular--portrait' style='background:#008000;color: #f8f8f8;font-size:3em;padding-top: 38px;;'>SYK</div>
Stryker is trading at 177.77 as of the 10th of July 2020. This is -0.0056 percent decrease since the beginning of the trading day. The stock's last reported lowest price was 176.07. Stryker has a very small chance of experiencing financial distress in the next few years but had a somewhat insignificant performance during the last 30 days. Equity ratings for Stryker are calculated daily based on the scoring framework. The performance scores are derived for the period starting the 11th of April 2020 and ending today, the 10th of July 2020. Click here to learn more.
Analyze Filter   Report: 30th of July 2020

4 100 

Stryker Profile

The upcoming quarterly report is expected on the 30th of July 2020. Stryker Corporation operates as a medical technology company. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan. Stryker operates under Medical Devices classification in the United States and is traded on BATS Exchange. It employs 40000 people. more on Stryker
Legal NameStryker
PresidentFinkView All
Thematic Classifications
Active investing themes Stryker currently participates. An investing theme is an unweighted collection of funds, stocks, ETFs or cryptocurrencies
    Obamacare Repeal
showing 2 out of 3 themes  View All
Average Analyst Recommendation
Current trade recommendation based on an ongoing consensus estimate among financial analysis covering Stryker. The Stryker consensus assessment is calculated by taking the average estimates from all of the analysts covering Stryker
Piotroski F Score
Academic score (developed by Joseph Piotroski in 2002) to determine the current strength of Stryker financial position. Scores of 8 and 9 are usually clasified strong value stocks whereas scores of 2 or below are considered weak value stocks.
 6 - HealthyDetails
Current ValueLast YearChange From Last Year 10 Year Trend
Weighted Average Shares416.5 M374 M
Moderately Up
Very volatile
Weighted Average Shares Diluted422.1 M379.9 M
Significantly Up
Net Cash Flow from Operations1.9 B2.2 B
Fairly Down
Slightly volatile
Total Assets32.5 B30.2 B
Significantly Up
Slightly volatile
Total Liabilities18.7 B17.4 B
Significantly Up
Slightly volatile
Current Assets9.6 B11.4 B
Fairly Down
Slightly volatile
Current Liabilities3.7 B4.4 B
Significantly Down
Slightly volatile
Total Debt6.7 B6.2 B
Significantly Up
Slightly volatile
Return on Average Assets8.937.2583
Fairly Up
Gross Margin72.7865.1438
Moderately Up
Very volatile
Asset Turnover0.630.5186
Fairly Up
Slightly volatile
Macroaxis Advice
Macroaxis buy hold or sell recommendation provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Stryker available fundamental, technical, and predictive indicators. Current horizon is 30 days (very short) - details
Strong SellFairly Valued
Financial Strength
Stryker financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Stryker success along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
A+ ( Average Bond Rating ) Very Firm
  Operating Cash Flow
Stryker (SYK) is traded on BATS Exchange in USA and employs 40,000 people. The company currently falls under 'Large-Cap' category with total capitalization of 69.05 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Stryker's market, we take the total number of its shares issued and multiply it by Stryker's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Stryker runs under Healthcare sector within Medical Devices industry. The entity has 375.38 M outstanding shares of which 3.16 M shares are at this time shorted by investors with about 1.92 days to cover shorted positions. STRYKER CP has about 4.05 B in cash with 2.47 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 10.78.
Check Stryker Probability Of Bankruptcy

Ownership Allocation (%)

Stryker Stock Price Odds Analysis

Odds Down 177.77HorizonTargetOdds Up 177.77
19.06%30 days
Based on a normal probability distribution, the odds of Stryker to move above the current price in 30 days from now is about 80.78 (This Stryker probability density function shows the probability of Stryker Stock to fall within a particular range of prices over 30 days) .

Stryker Stock Institutional Holders

InstituionSecurity TypeTotal SharesValue
Confluence Investment Management LlcCommon Shares342 K61.6 M
First Financial BanCommon Shares54.9 K9.9 M
View Stryker Diagnostics

Stryker Income Statement Over Time

Stryker Income Statement is one of the three primary financial statements used for reporting Stryker's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Stryker revenue and expense. Stryker Income Statement primarily focuses on the company's revenues and expenses during a particular period. Stryker Research and Development Expense is increasing as compared to previous years. The last year's value of Research and Development Expense was reported at 643.5 Million. The current Weighted Average Shares is estimated to increase to about 416.5 M, while Earning Before Interest and Taxes EBIT is estimated to decrease to under 1.4 B. View More Fundamentals

Stryker Stock Against Markets

Did you try this?

Run Commodity Channel Index Now


Commodity Channel Index

Use Commodity Channel Index to analyze current equity momentum
All  Next Launch Module

Stryker Upcoming and Recent Events

Stryker Company Earnings Announcements Dates

Upcoming Quarterly Report30th of July 2020
Next Earnings Report3rd of November 2020
Next Fiscal Quarter End30th of June 2020
Next Fiscal Year End26th of January 2021
Last Quarter Report31st of March 2020
Last Earning Announcement30th of June 2019

Stryker Distributions to stockholders

A dividend is the distribution of a portion of Stryker earnings, decided and managed by the Strykers board of directors and paid to a class of its shareholders. Note, announcements of dividend payouts are generally accompanied by a proportional increase or decrease in a company's stock price. Stryker dividend payments follow a chronological order of events, and the associated dates are important to determine the shareholders who qualify for receiving the dividend payment.
29th of June 2020
30th of March 2020
30th of December 2019
27th of September 2019
27th of June 2019
28th of March 2019
28th of December 2018
27th of September 2018
Additionally, take a look at World Market Map. Please also try Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Company logos by clearbit
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page